Real-life experience of upadacitinib for the treatment of adult patients with moderate-to-severe atopic dermatitis: a case series

G. Feraru, M. J. Nevet, L. Samuelov, E. Hodak, E. Avitan-Hersh, M. Ziv, R. P. Dodiuk-Gad

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e832-e833
JournalJournal of the European Academy of Dermatology and Venereology
Issue number10
StatePublished - Oct 2022


  • Adult
  • Dermatitis, Atopic/drug therapy
  • Heterocyclic Compounds, 3-Ring/adverse effects
  • Humans
  • Severity of Illness Index
  • Treatment Outcome

ASJC Scopus subject areas

  • Infectious Diseases
  • Dermatology

Cite this